Biomarkers in congenital heart disease: do natriuretic peptides hold the key?
about
Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology.Homoarginine-A prognostic indicator in adolescents and adults with complex congenital heart disease?Heart failure in adult congenital heart disease.
P2860
Biomarkers in congenital heart disease: do natriuretic peptides hold the key?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biomarkers in congenital heart disease: do natriuretic peptides hold the key?
@en
type
label
Biomarkers in congenital heart disease: do natriuretic peptides hold the key?
@en
prefLabel
Biomarkers in congenital heart disease: do natriuretic peptides hold the key?
@en
P2860
P356
P1476
Biomarkers in congenital heart disease: do natriuretic peptides hold the key?
@en
P2093
Konstantinos Dimopoulos
Rafael Alonso-Gonzalez
P2860
P304
P356
10.1586/ERC.13.14
P577
2013-06-01T00:00:00Z